Camber Capital Management
Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, ZBH, UHS, BAX, THC, and represent 50.15% of Camber Capital Management's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$105M), BIIB (+$86M), JAZZ (+$57M), QGEN (+$52M), DNLI (+$31M), BMRN (+$22M), WBA (+$17M), REPL (+$14M), GMED (+$13M), HLF (+$10M).
- Started 6 new stock positions in QGEN, DNLI, BMRN, TBPH, GMAB, BIIB.
- Reduced shares in these 10 stocks: THC (-$194M), UHS (-$113M), IONS (-$44M), RARE (-$43M), PFE (-$39M), QDEL (-$30M), SRPT (-$28M), VTRS (-$27M), Qiagen Nv (-$27M), MRNA (-$25M).
- Sold out of its positions in ASND, QDEL, HRMY, IONS, MRNA, SLDB, RARE, Qiagen Nv.
- Camber Capital Management was a net seller of stock by $-229M.
- Camber Capital Management has $4.1B in assets under management (AUM), dropping by 3.99%.
- Central Index Key (CIK): 0001444043
Tip: Access up to 7 years of quarterly data
Positions held by Camber Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 36 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 28.2 | $1.2B | +10% | 2.2M | 523.07 |
|
| Zimmer Holdings (ZBH) | 6.2 | $254M | 1.9M | 131.98 |
|
|
| Universal Hlth Svcs CL B (UHS) | 5.6 | $228M | -33% | 1.3M | 182.46 |
|
| Baxter International (BAX) | 5.2 | $214M | 5.0M | 42.74 |
|
|
| Tenet Healthcare Corp Com New (THC) | 4.9 | $200M | -49% | 1.9M | 105.11 |
|
| Viatris (VTRS) | 4.8 | $194M | -12% | 16M | 11.94 |
|
| Walgreen Boots Alliance (WBA) | 4.1 | $169M | +11% | 7.8M | 21.69 |
|
| Myriad Genetics (MYGN) | 4.0 | $163M | 7.6M | 21.32 |
|
|
| Medtronic SHS (MDT) | 4.0 | $161M | 1.9M | 87.15 |
|
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.4 | $139M | +70% | 1.2M | 120.42 |
|
| Globus Med Cl A (GMED) | 3.3 | $134M | +11% | 2.5M | 53.64 |
|
| Ptc Therapeutics I (PTCT) | 2.9 | $116M | 4.0M | 29.09 |
|
|
| Select Medical Holdings Corporation (SEM) | 2.5 | $103M | 3.4M | 30.15 |
|
|
| Brookdale Senior Living (BKD) | 2.5 | $103M | 16M | 6.61 |
|
|
| GSK Sponsored Adr (GSK) | 2.3 | $93M | 2.2M | 42.87 |
|
|
| Biogen Idec (BIIB) | 2.1 | $86M | NEW | 400k | 215.63 |
|
| Sarepta Therapeutics (SRPT) | 1.9 | $76M | -26% | 585k | 129.46 |
|
| Pfizer Call Option (PFE) | 1.7 | $69M | -36% | 2.5M | 27.75 |
|
| Zimvie (ZIMV) | 1.3 | $54M | 3.3M | 16.49 |
|
|
| Qiagen Nv Shs New (QGEN) | 1.3 | $52M | NEW | 1.2M | 42.99 |
|
| Perrigo SHS (PRGO) | 1.2 | $49M | -17% | 1.5M | 32.19 |
|
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $33M | -18% | 853k | 38.82 |
|
| Denali Therapeutics (DNLI) | 0.8 | $31M | NEW | 1.5M | 20.52 |
|
| Herbalife Com Shs (HLF) | 0.7 | $30M | +50% | 3.0M | 10.05 |
|
| OraSure Technologies (OSUR) | 0.6 | $26M | 4.3M | 6.15 |
|
|
| Brookdale Sr Living Unit 11/15/2025 (BKDT) | 0.6 | $23M | 250k | 90.76 |
|
|
| Replimune Group (REPL) | 0.6 | $23M | +175% | 2.8M | 8.17 |
|
| BioMarin Pharmaceutical (BMRN) | 0.5 | $22M | NEW | 250k | 87.34 |
|
| Peloton Interactive Cl A Com (PTON) | 0.5 | $19M | 4.5M | 4.29 |
|
|
| Inogen (INGN) | 0.4 | $16M | 2.0M | 8.07 |
|
|
| The Beauty Health Company Com Cl A (SKIN) | 0.4 | $16M | 3.5M | 4.44 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.3 | $11M | 450k | 24.90 |
|
|
| Theravance Biopharma (TBPH) | 0.2 | $9.0M | NEW | 1.0M | 8.97 |
|
| Puma Biotechnology (PBYI) | 0.2 | $8.7M | -41% | 1.7M | 5.30 |
|
| Curevac N V (CVAC) | 0.1 | $5.3M | 1.8M | 3.03 |
|
|
| Genmab A/s Sponsored Ads (GMAB) | 0.0 | $1.5M | NEW | 50k | 29.92 |
|
Past Filings by Camber Capital Management
SEC 13F filings are viewable for Camber Capital Management going back to 2010
- Camber Capital Management 2024 Q1 filed May 15, 2024
- Camber Capital Management 2023 Q4 filed Feb. 14, 2024
- Camber Capital Management 2023 Q3 filed Nov. 14, 2023
- Camber Capital Management 2023 Q2 filed Aug. 14, 2023
- Camber Capital Management 2023 Q1 filed May 15, 2023
- Camber Capital Management 2022 Q4 filed Feb. 14, 2023
- Camber Capital Management 2022 Q3 filed Nov. 14, 2022
- Camber Capital Management 2022 Q2 filed Aug. 15, 2022
- Camber Capital Management 2022 Q1 filed May 16, 2022
- Camber Capital Management 2021 Q4 filed Feb. 14, 2022
- Camber Capital Management 2021 Q3 filed Nov. 15, 2021
- Camber Capital Management 2021 Q2 filed Aug. 16, 2021
- Camber Capital Management 2021 Q1 filed May 17, 2021
- Camber Capital Management 2020 Q4 filed Feb. 16, 2021
- Camber Capital Management 2020 Q3 restated filed Nov. 16, 2020
- Camber Capital Management 2020 Q3 filed Nov. 16, 2020